Table 3 Correlation of GATA gene expression level with overall survival in ovarian can cer patients with different clinical stage

GATA-1

210446_at

I

56

0.66

0.26-1.69

0.38

II

324

0.81

0.58-1.13

0.20

III

1015

0.89

0.74-1.07

0.21

IV

20

0.37

0.10-1.35

0.12

GATA-2

207954_at

I

56

0.60

0.19-1.87

0.38

II

324

0.83

0.61-1.13

0.24

III

1015

0.78

0.65-0.94

0.0083

IV

20

0.64

0.22-1.88

0.41

GATA-3

209603_at

I

56

7.64

1.01-57.67

0.02

II

324

1.36

0.98-1.89

0.066

III

1015

1.15

0.98-1.36

0.095

IV

20

1.65

0.64-4.27

0.29

GATA-4

205517_at

I

74

4.28

0.55-33.2

0.13

II

61

0.34

0.11-1.03

0.045

III

1044

0.81

0.68-0.96

0.017

IV

176

1.30

0.82-2.05

0.26

GATA-5

238095_at

I

41

4.12

1.30-12.99

0.0088

II

162

0.77

0.47-1.24

0.27

III

392

0.75

0.58-0.96

0.022

IV

18

–

–

–

GATA-6

210002_at

I

56

1.65

0.63-4.31

0.30

II

324

1.24

0.89-1.72

0.20

III

1015

1.41

1.19-1.67

6e-05

IV

20

6.38

1.75-23.20

0.0017

TRPS1

218502_s_at

I

56

1.80

0.70-4.66

0.22

II

324

1.33

0.98-1.80

0.068

III

1015

1.12

0.94-1.34

0.21

IV

20

2.79

0.77-10.05

0.10